NCT03126435 2023-05-06EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOXSynCore Biotechnology Co., Ltd.Phase 3 Completed218 enrolled 19 charts